290 related articles for article (PubMed ID: 8291935)
1. [Technetium TC 99m pyrophosphate myocardial scintigraphy in amyloidosis. Correlations with Doppler echocardiography].
Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams A; Desgrez A; Blondeau M
Arch Mal Coeur Vaiss; 1993 Jul; 86(7):1009-15. PubMed ID: 8291935
[TBL] [Abstract][Full Text] [Related]
2. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
Gertz MA; Brown ML; Hauser MF; Kyle RA
Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
[TBL] [Abstract][Full Text] [Related]
3. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
[TBL] [Abstract][Full Text] [Related]
4. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
7. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography.
Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams D; Desgrez A; Blondeau M
Am J Cardiol; 1993 Oct; 72(11):854-7. PubMed ID: 8213531
[No Abstract] [Full Text] [Related]
9. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
Eriksson P; Backman C; Bjerle P; Eriksson A; Holm S; Olofsson BO
Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
[TBL] [Abstract][Full Text] [Related]
10. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
[TBL] [Abstract][Full Text] [Related]
11. [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].
Montes J; López L; Martín F; Pinedo JI; Galván R; Ortiz Berrocal J
Rev Esp Cardiol; 1985; 38(4):300. PubMed ID: 2996085
[No Abstract] [Full Text] [Related]
12. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial pyrophosphate uptake in cardiac amyloidosis: report of case].
Redondo F; González P; Ramírez A
Rev Med Chil; 2002 Mar; 130(3):315-8. PubMed ID: 12043375
[TBL] [Abstract][Full Text] [Related]
14. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis.
Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M
Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996
[No Abstract] [Full Text] [Related]
15. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
16. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
[TBL] [Abstract][Full Text] [Related]
17. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.
Janssen S; Piers DA; van Rijswijk MH; Meijer S; Mandema E
Eur J Nucl Med; 1990; 16(8-10):663-70. PubMed ID: 2166666
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
19. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
20. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
